| dc.contributor.author | Patel, B | en_US |
| dc.contributor.author | Kirkwood, AA | en_US |
| dc.contributor.author | Dey, A | en_US |
| dc.contributor.author | Marks, DI | en_US |
| dc.contributor.author | McMillan, AK | en_US |
| dc.contributor.author | Menne, TF | en_US |
| dc.contributor.author | Micklewright, L | en_US |
| dc.contributor.author | Patrick, P | en_US |
| dc.contributor.author | Purnell, S | en_US |
| dc.contributor.author | Rowntree, CJ | en_US |
| dc.contributor.author | Smith, P | en_US |
| dc.contributor.author | Fielding, AK | en_US |
| dc.date.accessioned | 2017-01-23T14:36:11Z | |
| dc.date.available | 2016-07-08 | en_US |
| dc.date.issued | 2017-01 | en_US |
| dc.date.submitted | 2017-01-20T17:48:01.875Z | |
| dc.identifier.issn | 0887-6924 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/18902 | |
| dc.description.sponsorship | UKALL14 was funded by Cancer Research UK grant CRUK/09/006 to AKF.
The MAAT testing and anti-asparaginase antibody testing was funded by an unrestricted educational grant from Medac GMBH to AKF.
BP was funded by Bloodwise grant 07062 to BP and AKF. | en_US |
| dc.format.extent | 58 - 64 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | LEUKEMIA | en_US |
| dc.title | Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial | en_US |
| dc.type | Article | |
| dc.rights.holder | (c) The Author(s), 2016 | |
| dc.identifier.doi | 10.1038/leu.2016.219 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394058700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 31 | en_US |
